EUVIMEDEUVIMED entdecken
Scoping ReviewOpen Access · CC BY 4.0

High-Flow Nasal Cannula in Pediatrics, Common Pediatric Respiratory Diseases and Potential Uses: A Scoping Review

Juan Francisco Guevara Ramírez, Andres Felipe Rodríguez Gutiérrez, Ingrid Sofía Sánchez Escobar, Samuel David Bolaños Rodríguez, Valentina Adames Restrepo, Simón Alejandro Ruiz Galvis, Valentina Sánchez Sánchez, Erwin Hernando Hernández, Samuel Barbosa

SN Comprehensive Clinical Medicine · 07.05.2026 · 8 (1)

DOI: 10.1007/s42399-026-02339-2 ↗

Kurz gefasst

Scoping Review in der Zeitschrift SN Comprehensive Clinical Medicine, online erschienen am 07.05.2026. Verfasst von Juan Francisco Guevara Ramírez und 8 weiteren Autor:innen. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of La Sabana.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

The growing use of high-flow nasal cannula (HFNC) in pediatric inpatient settings raises questions about its efficacy, safety, and cost-effectiveness compared to other non-invasive ventilation (NIV) systems. This scoping review synthesizes available evidence on the indications, benefits, and risks of HFNC in the pediatric population to identify its primary applications and key research priorities.

Methods

We conducted a scoping systematic review by retrieving articles from PubMed, Scopus, and Google Scholar databases, adhering to PRISMA-ScR guidelines. Studies published since 2017 were included, with a focus on the application of HFNC in bronchiolitis, asthma, pneumonia, and obstructive sleep apnea (OSA). Key parameters analyzed included dosing, clinical indications, and efficacy outcomes.

Results

Among the 44 selected articles, the evidence demonstrated mixed results across different pathologies. The strongest supporting evidence was consistently observed in the treatment of bronchiolitis and its effective use as a rescue or intermediate therapy in critical conditions.

Conclusions

The absence of standardized protocols and variability in dosing limit the widespread application of HFNC. While initial costs are reportedly high, its use may reduce the need for other therapeutic resources and pediatric intensive care unit (PICU) stays, offering long-term economic benefits. There is an urgent need for rigorously designed controlled studies to establish clear indications, optimize its use, and promote its inclusion in pediatric respiratory management guidelines.

Förderung

  • University of La Sabana

Zitieren

APA

Ramírez, J. F. G., Gutiérrez, A. F. R., Escobar, I. S. S., Rodríguez, S. D. B., Restrepo, V. A., Galvis, S. A. R., Sánchez, V. S., Hernández, E. H., & Barbosa, S. (2026). High-Flow Nasal Cannula in Pediatrics, Common Pediatric Respiratory Diseases and Potential Uses: A Scoping Review. SN Comprehensive Clinical Medicine, 8(1). https://doi.org/10.1007/s42399-026-02339-2

Vancouver

Ramírez JFG, Gutiérrez AFR, Escobar ISS, Rodríguez SDB, Restrepo VA, Galvis SAR, et al. High-Flow Nasal Cannula in Pediatrics, Common Pediatric Respiratory Diseases and Potential Uses: A Scoping Review. SN Comprehensive Clinical Medicine. 2026;8(1). doi:10.1007/s42399-026-02339-2

BibTeX
@article{Ramrez2026,
  author = {Ramírez, Juan Francisco Guevara and Gutiérrez, Andres Felipe Rodríguez and Escobar, Ingrid Sofía Sánchez and Rodríguez, Samuel David Bolaños and Restrepo, Valentina Adames and Galvis, Simón Alejandro Ruiz and Sánchez, Valentina Sánchez and Hernández, Erwin Hernando and Barbosa, Samuel},
  title = {High-Flow Nasal Cannula in Pediatrics, Common Pediatric Respiratory Diseases and Potential Uses: A Scoping Review},
  journal = {SN Comprehensive Clinical Medicine},
  year = {2026},
  volume = {8},
  number = {1},
  doi = {10.1007/s42399-026-02339-2}
}
Kostenlos starten →